Other Clinical Trial - HLH Patients - a Retrospective Study

Status Completed

Clinical Trial Summary

Monocentric, observational, retrospective, no profit study aimed to analyze factors that are significantly impacting the outcome of patients diagnosed with HLH.

Clinical Trial Description

retrospective data collection to study: type of HLH familial vs secondary, sex, age, presence of infectious cause, involvement central nervous system ( SNC), hepatic involvement, presence of hemophagocytosis, presence of splenomegaly, presence of involvement of other organs, the value of neutrophils (PMN), the value of hemoglobin, platelets, albumin, triglycerides, ferritin, LDH, type of therapy and the response to therapy after 2 months ;

Study Design

Related Conditions & MeSH terms

Hemophagocytic Lymphohistiocytoses
Lymphohistiocytosis, Hemophagocytic

Clinical Trial Details

NCT number	NCT05531721
Study type	Observational
Source	Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Contact
Status	Completed
Phase
Start date	November 10, 2022
Completion date	April 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05491304` - Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis	Phase 4
Not yet recruiting	`NCT05600959` - Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Completed	`NCT03546101` - Early Detection of Epstein-Barr Virus Related Disease.
Recruiting	`NCT05898477` - Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Recruiting	`NCT05882175` - Prospective Validation of the OHI Index
Recruiting	`NCT05146336` - CytOSorb TreatMent Of Critically Ill PatientS Registry
Not yet recruiting	`NCT04902807` - Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Terminated	`NCT03985423` - A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH	Phase 2/Phase 3
Completed	`NCT03513328` - Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation	Phase 1/Phase 2
Not yet recruiting	`NCT05677178` - Response Prediction in EBV-HLH Using Metabonomics Analysis
Recruiting	`NCT03117010` - Prospective Cohort for Adult Hemophagocytosis
Not yet recruiting	`NCT06160791` - Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)	Phase 2
Recruiting	`NCT05236764` - Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion	N/A
Recruiting	`NCT05277272` - INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
Completed	`NCT06047210` - Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
Not yet recruiting	`NCT05988177` - Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections	N/A